Bicocca Open Archive

Logo unimib boa

Canavesi, G., Mena, M., Zaninetta, E., Gazzola, L., Bini, T., Orofino, G., et al. (2024). Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort. In Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual (pp.86-88).

Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

Paolo Bonfanti;
2024
abstract + poster
HIV
English
HIV Glasgow 2024 - 10–13 November 2024
2024
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual
2024
27
S6
86
88
P074
https://onlinelibrary.wiley.com/doi/10.1002/jia2.26370
open
Canavesi, G., Mena, M., Zaninetta, E., Gazzola, L., Bini, T., Orofino, G., et al. (2024). Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort. In Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual (pp.86-88).
02 - Intervento a convegno
File in questo prodotto:
File Dimensione Formato  
Canavesi-2024-HIV Glasgow-VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 5.28 MB
Formato Adobe PDF
Visualizza/Apri
5.28 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/526244
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact